Synthetic Blood
A team of Researchers, led by Dr. Dipanjan Pan of Penn State, have been developing synthetic blood for over a decade to address critical needs in emergency and battlefield medicine. Their nanoparticle-based product mimics red blood cells, delivering oxygen safely without the need for blood type matching or refrigeration. Designed as emergency bridging therapy, it helps trauma patients during transport. Biodegradable and long-lasting, this innovation addresses critical gaps in emergency care, supported by a multi-disciplinary team and startup.
